JP2022541911A5 - - Google Patents
Info
- Publication number
- JP2022541911A5 JP2022541911A5 JP2022503918A JP2022503918A JP2022541911A5 JP 2022541911 A5 JP2022541911 A5 JP 2022541911A5 JP 2022503918 A JP2022503918 A JP 2022503918A JP 2022503918 A JP2022503918 A JP 2022503918A JP 2022541911 A5 JP2022541911 A5 JP 2022541911A5
- Authority
- JP
- Japan
- Prior art keywords
- carrier protein
- amino acid
- modified carrier
- derived
- modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19187963.4A EP3770269A1 (en) | 2019-07-23 | 2019-07-23 | Quantification of bioconjugate glycosylation |
| EP19187963.4 | 2019-07-23 | ||
| PCT/EP2020/070595 WO2021013854A1 (en) | 2019-07-23 | 2020-07-21 | Quantification of bioconjugate glycosylation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022541911A JP2022541911A (ja) | 2022-09-28 |
| JP2022541911A5 true JP2022541911A5 (cg-RX-API-DMAC7.html) | 2023-07-07 |
Family
ID=67438602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022503918A Pending JP2022541911A (ja) | 2019-07-23 | 2020-07-21 | バイオコンジュゲートグリコシル化の定量化 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220257751A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3770269A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022541911A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114302890A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022001034A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3147700A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022000880A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021013854A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022083585A1 (zh) * | 2020-10-20 | 2022-04-28 | 上海瑞宙生物科技有限公司 | 一种蛋白多糖结合物及其应用 |
| EP4409035A4 (en) * | 2021-09-30 | 2026-01-07 | Venn Biosciences Corp | SYSTEMS AND METHODS FOR DETERMINING GLYCOPEPTIDE CONCENTRATION, DETERMINING STANDARDIZED ABUNDANCE, AND PREPARING SAMPLES FOR LC/MS |
| WO2025172892A1 (en) * | 2024-02-16 | 2025-08-21 | Glaxosmithkline Biologicals Sa | Modified proteins and methods |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235877A (en) | 1979-06-27 | 1980-11-25 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| KR100310510B1 (ko) | 1993-03-23 | 2002-07-04 | 장 스테판느 | 3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물 |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| AU713040B2 (en) | 1994-07-15 | 1999-11-18 | University Of Iowa Research Foundation, The | Immunomodulatory oligonucleotides |
| GB9718901D0 (en) | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
| EP1279401B1 (en) | 1997-09-05 | 2008-01-09 | GlaxoSmithKline Biologicals S.A. | Oil in water emulsions containing saponins |
| DK1481057T3 (da) | 2002-03-07 | 2006-05-15 | Eidgenoess Tech Hochschule | System og fremgangsmåde til fremstilling af rekombinante glycosylerede proteiner i en prokaryot vært |
| ES2535084T3 (es) | 2005-05-11 | 2015-05-05 | Eth Zurich | Proteínas N-glicosiladas recombinantes procedentes de células procariotas |
| ATE539079T1 (de) | 2006-03-23 | 2012-01-15 | Novartis Ag | Imidazochinoxalinverbindungen als immunmodulatoren |
| CA2646891A1 (en) | 2006-03-23 | 2007-09-27 | Novartis Ag | Immunopotentiating compounds |
| SI2257307T1 (sl) | 2008-02-20 | 2018-09-28 | Glaxosmithkline Biologicals S.A. | Biokonjugati, izdelani iz rekombinantnih N-glikoziliranih proteinov iz prokariontskih celic |
| US20110189223A1 (en) | 2008-04-16 | 2011-08-04 | Glaxosmithkline Biologicals S.A. | Vaccine |
| KR20110009157A (ko) | 2008-04-16 | 2011-01-27 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 백신 |
| JP2012533285A (ja) | 2009-07-17 | 2012-12-27 | オーシャン ハーベスト テクノロジー (カナダ) インコーポレイテッド | 魚用飼料中の合成添加物を置換する、天然かつ持続可能な海藻配合物 |
| NO2501406T3 (cg-RX-API-DMAC7.html) | 2009-11-19 | 2018-05-19 | ||
| WO2011138361A1 (en) | 2010-05-06 | 2011-11-10 | Glycovaxyn | Capsular gram-positive bacteria bioconjugate vaccines |
| CA2847621A1 (en) * | 2011-09-06 | 2013-03-14 | Glycovaxyn Ag | Bioconjugate vaccines made in prokaryotic cells |
| WO2014037585A1 (en) | 2012-09-10 | 2014-03-13 | Glycovaxyn Ag | Bioconjugates comprising modified antigens and uses thereof |
| KR20150068998A (ko) | 2012-10-12 | 2015-06-22 | 글리코박신 아게 | 숙주 세포 변형 방법 |
| EP2917351B1 (en) | 2012-11-07 | 2018-12-19 | GlaxoSmithKline Biologicals S.A. | Production of recombinant vaccine in e. coli by enzymatic conjugation |
| AR104469A1 (es) | 2014-08-08 | 2017-07-26 | Glycovaxyn Ag | Células huésped modificadas para su uso en producción de bioconjugados |
| SI3240895T1 (sl) | 2014-12-30 | 2022-04-29 | Glaxosmithkline Biologicals S.A. | Sestavki in postopki za glikozilacijo proteinov |
| GB201518668D0 (en) * | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Immunogenic Comosition |
| GB201721576D0 (en) * | 2017-12-21 | 2018-02-07 | Glaxosmithkline Biologicals Sa | Hla antigens and glycoconjugates thereof |
| GB201721582D0 (en) | 2017-12-21 | 2018-02-07 | Glaxosmithkline Biologicals Sa | S aureus antigens and immunogenic compositions |
-
2019
- 2019-07-23 EP EP19187963.4A patent/EP3770269A1/en active Pending
-
2020
- 2020-07-21 CA CA3147700A patent/CA3147700A1/en active Pending
- 2020-07-21 JP JP2022503918A patent/JP2022541911A/ja active Pending
- 2020-07-21 CN CN202080060466.4A patent/CN114302890A/zh active Pending
- 2020-07-21 MX MX2022000880A patent/MX2022000880A/es unknown
- 2020-07-21 BR BR112022001034A patent/BR112022001034A2/pt not_active Application Discontinuation
- 2020-07-21 US US17/628,667 patent/US20220257751A1/en active Pending
- 2020-07-21 EP EP20740641.4A patent/EP4004224A1/en active Pending
- 2020-07-21 WO PCT/EP2020/070595 patent/WO2021013854A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240100140A1 (en) | Immunogenic composition | |
| Maleki Kakelar et al. | Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination | |
| US20190282682A1 (en) | Modified host cells and hybrid oligosaccharides for use in bioconjugate production | |
| CN113950524B (zh) | 生产大肠杆菌o-抗原多糖的生物缀合物的方法、其组合物及其使用方法 | |
| JP6682451B2 (ja) | 改変型宿主細胞およびその使用 | |
| JP2019030309A (ja) | 酵素的コンジュゲート化による大腸菌での組み換えワクチンの製造 | |
| US11406696B2 (en) | P aeruginosa PcrV-linked antigen vaccines | |
| CN113924112A (zh) | 大肠杆菌o-抗原多糖的生物缀合物、其生产方法及其使用方法 | |
| CN106535927A (zh) | 新颖多糖及其用途 | |
| CN115803087B (zh) | 多价疫苗组合物及其用途 | |
| US12128096B2 (en) | Immunogenic composition | |
| Fox et al. | Novel lipopolysaccharide biosynthetic genes containing tetranucleotide repeats in Haemophilus influenzae, identification of a gene for adding O‐acetyl groups | |
| AU2012306345A1 (en) | Bioconjugate vaccines made in prokaryotic cells | |
| WO2006065137A2 (en) | Novel efficient production process for capsular polysaccharides of pathogenic grampositive bacteria by heterologous expression and secretion of complex polysaccharides in non-pathogenic, non-invasive gram- positive bacteria | |
| Skurnik | Molecular genetics, biochemistry and biological role of Yersinia lipopolysaccharide | |
| TW202304504A (zh) | 大腸桿菌o18生物軛合物之生產 | |
| Chaffin et al. | CpsK of Streptococcus agalactiae exhibits α2, 3‐sialyltransferase activity in Haemophilus ducreyi | |
| US20240139304A1 (en) | P aeruginosa pcrv-linked antigen vaccines | |
| JP2023530154A5 (cg-RX-API-DMAC7.html) | ||
| EA047805B1 (ru) | Получение биоконъюгатов e.coli o18 | |
| Oldfield | The genetic basis of lipopolysaccharide biosynthesis in Campylobacter jejuni | |
| Jankovic | Characterisation of the lex2B gene and its role in LPS biosynthesis in Campylobacter jejuni |